LGT Financial Advisors’s CONMED CNMD Stock Holding History

LGT Financial Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-58	Closed	-$3.97K	–	384
2024 Q4	$3.97K	Hold	58	–	–	0.01%	586
2024 Q3	$4.17K	Hold	58	–	–	0.01%	565
2024 Q2	$4.02K	Hold	58	–	–	0.01%	631
2024 Q1	$4.64K	Hold	58	–	–	0.01%	632
2023 Q4	$6.35K	Hold	58	–	–	0.01%	571
2023 Q3	$5.85K	Buy	+58	New	+$6.66K	0.01%	581

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

LGT Financial Advisors's CNMD Position: Q1 2025 in Review

LGT Financial Advisors sold out of CONMED (CNMD) in Q1 2025, closing a stake of 58 shares — an estimated $3.97K sold.

LGT Financial Advisors first reported a position in CNMD in Q3 2023 and held it in 6 quarters. The position peaked at $6.35K in Q4 2023. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

LGT Financial Advisors reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
LGT Financial Advisors sold 58 CONMED shares in Q1 2025, an estimated $3.97K.
LGT Financial Advisors first reported a position in CONMED in Q3 2023 and held it in 6 quarters.
LGT Financial Advisors's CONMED position peaked at $6.35K in Q4 2023.
280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on LGT Financial Advisors's 13F filing for Q1 2025, filed 8 May 2025.